Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes - Wikidata - awgldk - TriplyDB

Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes

Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes

http://www.wikidata.org/entity/Q34783357

about

Efficacy and safety of premixed insulin analogs in Asian patients with type 2 diabetes: A systematic review Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations.Relative Contribution of Fasting and Postprandial Blood Glucose in Overall Glycemic Control: Post Hoc Analysis of a Phase IV Randomized Trial.

P2860

Q33871367-7BB6C943-B7B3-496A-BD7D-42DF0B9EB8B6 Q50108204-75164AB1-0D8A-4304-ADCE-37226AD2C488 Q51244515-FD31DF15-DF8D-41A4-AB96-502D9A561C72

P2860

Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes

http://www.wikidata.org/entity/Q34783357

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effectiveness and safety of Hu ...... patients with type 2 diabetes

@ast

Effectiveness and safety of Hu ...... patients with type 2 diabetes

@en

Effectiveness and safety of Hu ...... patients with type 2 diabetes

@nl

type

label

Effectiveness and safety of Hu ...... patients with type 2 diabetes

@ast

Effectiveness and safety of Hu ...... patients with type 2 diabetes

@en

Effectiveness and safety of Hu ...... patients with type 2 diabetes

@nl

prefLabel

Effectiveness and safety of Hu ...... patients with type 2 diabetes

@ast

Effectiveness and safety of Hu ...... patients with type 2 diabetes

@en

Effectiveness and safety of Hu ...... patients with type 2 diabetes

@nl

P1433

Q34783357-398228AD-B063-4946-ABE1-B4DC9C4393E9

P1476

Q34783357-46ABBC2F-9D41-481C-9000-7D8DD44AFE35

P2093

Q34783357-3CE2E0CB-1ED8-4F6A-90F5-0D58024AF9BE

Q34783357-BEDA60FC-6A04-4906-B312-6FA7BB794A9F

Q34783357-CD463604-693C-4308-A061-74736FAD260F

P2860

Q34783357-086605DF-0A4C-4726-BF03-2BD53D18FF8D

Q34783357-12ACF1BA-DE74-441E-A8A8-512763811766

Q34783357-16AB7638-D126-4280-A6EF-7B2752DC82F2

Q34783357-186FBF53-8B78-4A01-BA2F-98E11B020989

Q34783357-3395E9BE-BF37-4814-890B-0D74DE5A0B8A

Q34783357-39C3F448-D059-4EFB-86CF-FE2475D1CE89

Q34783357-4ADBAD25-BC87-4BA5-819F-9B21716CA50F

Q34783357-537795DE-8EF5-49A3-9A16-9B78ACE2F341

Q34783357-6AD1C96E-A933-488E-A499-D951375828E5

Q34783357-6E9D43C4-17C4-4A57-8F60-FB1259BF768B

P304

Q34783357-06A21E17-6E89-4D17-855E-D8B700F34237

P31

Q34783357-1CCF1B89-BA8B-49F7-9377-2A5CBDC64E1D

P356

Q34783357-5E10C8FF-2965-4E01-9779-2A06DDAA8383

P478

Q34783357-B573D684-943C-4F77-B256-AAF7F51C1582

P50

Q34783357-B79F1171-E3F5-41D7-95DA-728E20B134A3

P577

Q34783357-E93C93B8-F482-4BB0-88A5-A697278FC03C

P698

Q34783357-E2A34FE0-8C9B-4613-A358-62BDA7B34CEA

P921

Q34783357-17693B7F-6379-493A-BCB5-C6FF0D90C8B0

P932

Q34783357-D179597E-DC55-463A-A4E4-695142AA3A07

P356

P1433

Therapeutics and Clinical Risk Management

P1476

Effectiveness and safety of Hu ...... patients with type 2 diabetes

@en

P2093

Feng Gao

http://www.w3.org/2001/XMLSchema#string

Raja Adeel Shafqat

http://www.w3.org/2001/XMLSchema#string

Xinquan Ai

http://www.w3.org/2001/XMLSchema#string

P2860

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Combination therapies with insulin in type 2 diabetes.

Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects

Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.

Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?

Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities.

Measuring outcomes of type 2 diabetes disease management program in an HMO setting.

Comparison of HbA1c in Chinese patients with type 1 or type 2 diabetes randomized to twice daily insulin lispro low mix 25 or twice daily human insulin mix 30/70.

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

P304

27-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S75602

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad Ishraq Zafar

P577

2014-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25565854

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4278736

http://www.w3.org/2001/XMLSchema#string